Clinical Trial Update: Study of Licarbazepine in the Treatment of Manic Episodes of Bipolar Disorder [Phase 3]

View source ↗

Summary

A Phase 3 trial investigating licarbazepine for manic episodes in bipolar disorder has completed enrollment and status is reported as completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder

Drugs mentioned

• Licarbazepine (licarbazepine)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Bipolar Disorder | Phase 3 | Status: COMPLETED